Ryo Akihide, Tsurutani Naomi, Ohba Kenji, Kimura Ryuichiro, Komano Jun, Nishi Mayuko, Soeda Hiromi, Hattori Shinichiro, Perrem Kilian, Yamamoto Mikio, Chiba Joe, Mimaya Jun-Ichi, Yoshimura Kazuhisa, Matsushita Shuzo, Honda Mitsuo, Yoshimura Akihiko, Sawasaki Tatsuya, Aoki Ichiro, Morikawa Yuko, Yamamoto Naoki
Department of Pathology, Yokohama City University School of Medicine, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan.
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):294-9. doi: 10.1073/pnas.0704831105. Epub 2008 Jan 2.
Human immunodeficiency virus type 1 (HIV-1) utilizes the macromolecular machinery of the infected host cell to produce progeny virus. The discovery of cellular factors that participate in HIV-1 replication pathways has provided further insight into the molecular basis of virus-host cell interactions. Here, we report that the suppressor of cytokine signaling 1 (SOCS1) is an inducible host factor during HIV-1 infection and regulates the late stages of the HIV-1 replication pathway. SOCS1 can directly bind to the matrix and nucleocapsid regions of the HIV-1 p55 Gag polyprotein and enhance its stability and trafficking, resulting in the efficient production of HIV-1 particles via an IFN signaling-independent mechanism. The depletion of SOCS1 by siRNA reduces both the targeted trafficking and assembly of HIV-1 Gag, resulting in its accumulation as perinuclear solid aggregates that are eventually subjected to lysosomal degradation. These results together indicate that SOCS1 is a crucial host factor that regulates the intracellular dynamism of HIV-1 Gag and could therefore be a potential new therapeutic target for AIDS and its related disorders.
1型人类免疫缺陷病毒(HIV-1)利用被感染宿主细胞的大分子机制来产生子代病毒。参与HIV-1复制途径的细胞因子的发现,为深入了解病毒与宿主细胞相互作用的分子基础提供了进一步的线索。在此,我们报告细胞因子信号传导抑制因子1(SOCS1)是HIV-1感染过程中的一种可诱导宿主因子,并调节HIV-1复制途径的后期阶段。SOCS1可直接结合HIV-1 p55 Gag多聚蛋白的基质和核衣壳区域,并增强其稳定性和运输,通过一种不依赖于IFN信号传导的机制导致HIV-1颗粒的高效产生。通过小干扰RNA(siRNA)耗尽SOCS1会减少HIV-1 Gag的靶向运输和组装,导致其作为核周固体聚集体积累,最终被溶酶体降解。这些结果共同表明,SOCS1是调节HIV-1 Gag细胞内动态变化的关键宿主因子,因此可能是治疗艾滋病及其相关疾病的潜在新靶点。